- Jan 21, 2000
- 137
- 0
- 0
ADVR...Waiting for approval of Reticlose,a topical HIV treatment.Presently conducting tests outside the US.
DNAP...Genetic mapping.Company is just 6 months old and was created out of a shell,is now on picksheets and will move to OTCBB this week or next.
IMDS....Waiting for FDA approval on their "Computed Tomography Laser Mommogaphy" (CTLM) This proceedure is very safe and painless.GE has the tech but does not match this product.
MADA.....Research is primarely in Alzheimers.
No Debt,S/O 44.03,Float 17.60
Institutions 17 hold
Zkem.....Xechem International is a biopharmaceutical company engaged in the research, development and production of generic and proprietary drugs from natural sources,dealing with antibiotics and anticancer compounds.The company also screens extracts and pure compounds from China,India and Indonesia for their therapeutic use.The potential for growth can be seen by the fact that if one of the company's paclitaxel analogs turns out to be good and the new formulation which is being tested now proves better,the company's situation could change dramatically in no time.Besides developing a process to make Taxol or Paclitaxel,our approach has also been to develop a new and better formulation of Taxol.Our process for the purification and isolation of Paclitaxel has been patented;we have a US patent and over 30 international patents are pending.
These are my top picks in the pennystocks,as always do your DD and solid investing.
DNAP...Genetic mapping.Company is just 6 months old and was created out of a shell,is now on picksheets and will move to OTCBB this week or next.
IMDS....Waiting for FDA approval on their "Computed Tomography Laser Mommogaphy" (CTLM) This proceedure is very safe and painless.GE has the tech but does not match this product.
MADA.....Research is primarely in Alzheimers.
No Debt,S/O 44.03,Float 17.60
Institutions 17 hold
Zkem.....Xechem International is a biopharmaceutical company engaged in the research, development and production of generic and proprietary drugs from natural sources,dealing with antibiotics and anticancer compounds.The company also screens extracts and pure compounds from China,India and Indonesia for their therapeutic use.The potential for growth can be seen by the fact that if one of the company's paclitaxel analogs turns out to be good and the new formulation which is being tested now proves better,the company's situation could change dramatically in no time.Besides developing a process to make Taxol or Paclitaxel,our approach has also been to develop a new and better formulation of Taxol.Our process for the purification and isolation of Paclitaxel has been patented;we have a US patent and over 30 international patents are pending.
These are my top picks in the pennystocks,as always do your DD and solid investing.